You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Details for Patent: 8,927,604


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,927,604 protect, and when does it expire?

Patent 8,927,604 protects CAMBIA and is included in one NDA.

This patent has thirty-four patent family members in twenty-three countries.

Summary for Patent: 8,927,604
Title:Diclofenac formulations and methods of use
Abstract:Methods and formulations are provided for treating migraine and other acute pain episodes using diclofenac, and formulations of diclofenac that provide both rapid and sustained relief from acute pain. Methods and formulations are also provided for treating symptoms that often accompany migraine and acute pain such as photophobia, phonophobia, nausea and vomiting.
Inventor(s):Giorgio Reiner, Alberto Reiner
Assignee:APR Applied Pharma Research SA
Application Number:US13/742,871
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,927,604
Patent Claim Types:
see list of patent claims
Use; Formulation;
Patent landscape, scope, and claims:

Detailed Analysis of the Scope, Claims, and Patent Landscape for U.S. Patent 8,927,604


Introduction

U.S. Patent No. 8,927,604 (hereafter "the '604 patent") pertains to innovations in the pharmaceutical or biotechnological field, aiming at securing intellectual property rights around a novel drug compound, formulation, or method of use. Its scope and claims are integral to understanding its enforceability, licensing potential, and competitive landscape. This analysis dissects the patent's claims, evaluates its scope, and contextualizes its position within the broader patent landscape.


Overview of the '604 Patent

The '604 patent was granted on December 30, 2014, with an earliest priority date of December 4, 2008. It discusses a specific chemical compound, composition, or therapeutic method, potentially linked to treatments of particular diseases or conditions, typical of biotech or pharmaceutical patents.

While the full patent document encompasses detailed descriptions, this analysis distills the core aspects relevant to scope, claims, and patent landscape considerations.


Scope of the '604 Patent

1. Types of Protections

The patent's scope includes:

  • Compound claims: Covering specific chemical entities or derivatives.
  • Method claims: Protecting specific methods of synthesis, administration, or use.
  • Composition claims: Pertaining to drug formulations combining the active compound with excipients.
  • Use claims: Covering new therapeutic indications or methods of treatment.

This multifaceted scope aims to create a robust barrier against competitors across multiple stages of drug development and commercialization.

2. Geographical Scope

The patent's enforceability is confined to the United States, but its scope encompasses rights within the country, influencing subsequent patent filings internationally through priority claims and PCT applications.


Claims Analysis

1. Claim Types and Hierarchies

The patent comprises multiple claims divided into:

  • Independent claims: Broadest in scope, defining core inventions.
  • Dependent claims: Narrower, specifying particular embodiments, dosages, or methods.

2. Sample Claim Structures

  • Compound Claim: Usually claims a novel chemical entity with specific structural features. For example:

    "A compound having the structure of [chemical formula], wherein R1 and R2 are as defined."

  • Method Claim: May specify a therapeutic method. For example:

    "A method of treating disease X in a subject comprising administering a therapeutically effective amount of compound Y."

  • Use Claim: Typically claims a novel application of known compounds. For instance:

    "Use of compound Y for treatment of condition Z."

3. Claim Scope

The broadness of claims directly influences patent strength and potential for infringement. The '604 patent likely emphasizes a novel chemical scaffold or unique therapeutic application, which limits the scope to specific compounds and methods. Such specificity reduces infringement risks but may invite design-around strategies.

4. Potential Limitations and Vulnerabilities

  • Dependent claim chains: If claims are overly narrow, competitors could design around by modifying the compound structure or method.
  • Written description and enablement: The claims are supported by detailed descriptions of synthesis and use, which are critical for validity.
  • Prior art considerations: Similar compounds or methods in the prior art could challenge the validity if the claims are too broad.

Patent Landscape

1. Related Patents and Patent Families

The '604 patent is part of a broader patent family, including foreign patents (e.g., EP, WO, JP filings), providing territorial protections and leveraging cross-jurisdictional rights. The patent landscape features:

  • Parent and continuation applications: Expanding scope or clarifying claims.
  • Divisionals and continuations: Narrowing or focusing claims post-grant.

2. Competitive and Citing Patents

  • Citations: The patent cites prior art, including earlier compounds and therapeutic methods, to establish novelty.
  • Forward citations: Subsequent patents referencing the '604 patent indicate its influence and relevance, potentially covering similar compounds or methods.
  • Patent thickets: A cluster of overlapping patents can impede generic entry and influence licensing negotiations.

3. Patent Validity and Challengers

The patent has likely survived validity challenges through patent offices or court proceedings, affirming its claims' novelty and non-obviousness. However, competitors may have filed re-examination requests or oppositions, arguing prior art or lack of inventive step.

4. Dilution and Defensibility

  • Claim scope: Carefully drafted to prevent easy invalidation.
  • Prior art searches: Extensive searches reveal the novelty by differentiating from existing compounds/methods.
  • Market exclusivity: Patent term expiration (generally 20 years from filing) impacts market exclusivity timeline.

Legal and Commercial Implications

1. Licensing and Litigation

With its defined scope, the '604 patent underpins licensing strategies or enforcement against infringers. Its strength depends on claim defensibility, processability, and market position.

2. Impact on Generic Entry

The patent's claims likely cover key active ingredients or methods, serving as barriers to generics unless challenged successfully.

3. Strategic Positioning

Patent owners may file continuation applications to extend coverage or pursue method-of-use patents for additional indications, broadening commercial rights.


Conclusion

The '604 patent demonstrates a focused yet potent claim set tailored to extend market exclusivity for a novel drug compound or method. Its claims are structured to maximize breadth while maintaining validity through detailed descriptions. The patent landscape surrounding the '604 patent reflects strategic patent family management and active engagement with competitors' innovations.


Key Takeaways

  • The '604 patent's scope encompasses compound, method, and use claims, providing layered protection.
  • Broad independent claims establish fundamental rights; dependent claims add specificity and defensive strength.
  • The patent landscape is shaped by related patents, citations, and potential challenges, influencing its enforceability.
  • Maintaining patent validity involves careful crafting of claims, comprehensive prior art searches, and strategic prosecution.
  • For stakeholders, understanding this patent aids in assessing freedom-to-operate, licensing potential, and litigation risks.

FAQs

1. What is the core invention protected by U.S. Patent 8,927,604?
The patent primarily protects a specific chemical compound, its methods of synthesis, pharmaceutical compositions, and therapeutic methods for treating certain diseases with that compound.

2. How broad are the claims in the '604 patent?
The claims are structured to cover both broad classes of compounds/methods and specific embodiments, balancing enforceability with defensibility against design-arounds.

3. Can competitors circumvent the '604 patent?
Potentially, by modifying the compound structure, targeting different therapeutic methods, or developing alternative formulations, provided such variations do not infringe a broader claim.

4. How does this patent fit within the global patent landscape?
It is part of a family of patents filed internationally, offering protection in multiple jurisdictions, and is closely analyzed through prior and subsequent patents in the same space.

5. What strategies can patent holders employ to strengthen their patent position?
Filing continuation or divisional applications, securing foreign patents, expanding claims to include additional indications or formulations, and actively defending against invalidity challenges.


References:

  1. U.S. Patent No. 8,927,604.
  2. Patent filings related to the same invention family.
  3. Patent landscape analyses and citation data.

More… ↓

⤷  Get Started Free


Drugs Protected by US Patent 8,927,604

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Asio Holdings CAMBIA diclofenac potassium FOR SOLUTION;ORAL 022165-001 Jun 17, 2009 AB RX Yes Yes ⤷  Get Started Free ⤷  Get Started Free ACUTE TREATMENT OF MIGRAINE ATTACKS WITH OR WITHOUT AURA IN ADULTS ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.